Pharmacology Flashcards

You may prefer our related Brainscape-certified flashcards:
1
Q

G-Protein α-Subunit Gs β-adrenoceptors; Histamine H2 receptors; Serotonin 5-HT4 receptors; Glucagon

A

↑adenylyl cyclase activity leading to ↑ levels of cyclic AMP

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

Gi1, Gi2,Gi3 α2-adrenoceptors; Muscarinic cholinergic M2 and M4; Serotonin 5-HT1; Opioids, cannbinoid

A

↓ adenylyl cyclase activity leading to ↓ levels of cyclic AMP; Open potassium channels

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

Gq Muscarinic cholinergic M1, M3 and M5; Serotonin 5-HT2; α1-adrenoceptors;

A

↑ phospholipase C activity leading to ↑ levels of IP3 and diacylglycerol that increase intracellular Ca2+

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

Target for GPCRs

A

Adenylyl cyclase, the enz responsible for Camp phospholipase C, the enzyme responsible for inositol phosphate and diacylglycerol (DAG) formation ion channels, particularly calcium and potassium channels

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

Therapeutic Uses of Direct-Acting Cholinergic Receptor Agonists Bethanechol

A

Postoperative ileus

Congenital megacolon

Urinary retention

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

Therapeutic Uses of Direct-Acting Cholinergic Receptor Agonists

Pilocarpine, Carbachol

A

Glaucoma

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

Edrophonium (Tensilon®)

, Tacrine (Cognex®),

Donepezil (Aricept®)

Galantamine (Reminyl®)

A

Indirect Acting Cholinomimetic Drugs:

Inhibitors of Acetylcholinesterase

Competitive Inhibitors

Reversible

Compete for ACh binding at the anionic site

Contains no ester linkage so that it is not hydrolyzed

Inhibition is rapidly reversible (increase Ach conc. will reverse their effect) DOA is not very long Tacrine discontinued due liver damage

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

Physostigmine,Rivastigmine (cross BBB)

Pyridostigmine, Neostigmine, (NOT CORSS BBB)

and Carbaryl, Propoxur and Aldicarb

A

Carbamate Inhibitors (garden products)

Reversible

They interact with 2 sites of the enzyme, the anionic site and they actually add carbamyl group to it.

Carbamyl ester linkage hydrolyzed to carbamylate enzyme Carbamyl moiety is slowly released - leads to long-lasting but reversible inhibition

Physostigmine and Rivastigmine are CNS permeable and used in treating Alzheimer’s disease

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

DFP (Isoflurophate); Echothiophate, (The only one therapeutically useful) Parathion, Tabun (GA), Sarin (GB), Soman (GF), VX (10x more potent than G-series)

A

Irreversible Inhibitors Used as insecticides and nerve gases Good CNS penetration (highly lipid soluble) Covalently phosphorylate the esteratic site of the enzyme (They phosphrylate that ser and the phosphrylation takes long time, good fortune) Phosphorylation is generally irreversible and enzyme must either be resynthesized or chemically reactivated by pralidoxime (2-PAM

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

Parathion,

A

Indirect Acting Cholinomimetic Drugs: Inhibitors of Acetylcholinesterase Irreversible Inhibitors Used as insecticides and nerve gases Good CNS penetration (highly lipid soluble) Covalently phosphorylate the esteratic site of the enzyme (They phosphrylate that ser and the phosphrylation takes long time, good fortune) Phosphorylation is generally irreversible and enzyme must either be resynthesized or chemically reactivated by pralidoxime (2-PAM

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

Tabun (GA)

A

Indirect Acting Cholinomimetic Drugs: Inhibitors of Acetylcholinesterase Irreversible Inhibitors Used as insecticides and nerve gases Good CNS penetration (highly lipid soluble) Covalently phosphorylate the esteratic site of the enzyme (They phosphrylate that ser and the phosphrylation takes long time, good fortune) Phosphorylation is generally irreversible and enzyme must either be resynthesized or chemically reactivated by pralidoxime (2-PAM

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

Sarin (GB),

A

Indirect Acting Cholinomimetic Drugs: Inhibitors of Acetylcholinesterase Irreversible Inhibitors Used as insecticides and nerve gases Good CNS penetration (highly lipid soluble) Covalently phosphorylate the esteratic site of the enzyme (They phosphrylate that ser and the phosphrylation takes long time, good fortune) Phosphorylation is generally irreversible and enzyme must either be resynthesized or chemically reactivated by pralidoxime (2-PAM

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

Soman (GF)

A

Indirect Acting Cholinomimetic Drugs: Inhibitors of Acetylcholinesterase Irreversible Inhibitors Used as insecticides and nerve gases Good CNS penetration (highly lipid soluble) Covalently phosphorylate the esteratic site of the enzyme (They phosphrylate that ser and the phosphrylation takes long time, good fortune) Phosphorylation is generally irreversible and enzyme must either be resynthesized or chemically reactivated by pralidoxime (2-PAM

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

VX (10x more potent than G-series)

A

Indirect Acting Cholinomimetic Drugs: Inhibitors of Acetylcholinesterase Irreversible Inhibitors Used as insecticides and nerve gases Good CNS penetration (highly lipid soluble) Covalently phosphorylate the esteratic site of the enzyme (They phosphrylate that ser and the phosphrylation takes long time, good fortune) Phosphorylation is generally irreversible and enzyme must either be resynthesized or chemically reactivated by pralidoxime (2-PAM

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

Carbaryl

A

Carbamate Inhibitors (garden products) Reversible They interact with 2 sites of the enzyme, the anionic site and they actually add carbamyl group to it. Carbamyl ester linkage hydrolyzed to carbamylate enzyme Carbamyl moiety is slowly released - leads to long-lasting but reversible inhibition Physostigmine and Rivastigmine are CNS permeable and used in treating Alzheimer’s disease

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

Propoxur

A

Carbamate Inhibitors (garden products) Reversible They interact with 2 sites of the enzyme, the anionic site and they actually add carbamyl group to it. Carbamyl ester linkage hydrolyzed to carbamylate enzyme Carbamyl moiety is slowly released - leads to long-lasting but reversible inhibition Physostigmine and Rivastigmine are CNS permeable and used in treating Alzheimer’s disease

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
17
Q

Aldicarb

A

Carbamate Inhibitors (garden products) Reversible They interact with 2 sites of the enzyme, the anionic site and they actually add carbamyl group to it. Carbamyl ester linkage hydrolyzed to carbamylate enzyme Carbamyl moiety is slowly released - leads to long-lasting but reversible inhibition Physostigmine and Rivastigmine are CNS permeable and used in treating Alzheimer’s disease

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
18
Q

Organ System Effects of Cholinesterase Inhibition Cardiovascular

A

Bradycardia Decreased Cardiac Output (CO) Hypotension (modest except in toxic doses

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
19
Q

Organ System Effects of Cholinesterase Inhibition Respiratory System

A

Bronchoconstriction Increased secretion (copious) Paralysis of diaphragm

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
20
Q

Organ System Effects of Cholinesterase Inhibition GI Tract

A

Increased tone Increased motility Increased secretions

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
21
Q

Organ System Effects of Cholinesterase Inhibition Skin

A

Increased sweating

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
22
Q

Organ System Effects of Cholinesterase Inhibition Eye

A

Miosis Near accommodation

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
23
Q

Organ System Effects of Cholinesterase Inhibition Central Nervous System

A

Tremor Anxiety Confusion Convulsions Coma

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
24
Q

Therapeutic Uses of Cholinesterase Inhibitors

A

Glaucoma Postoperative ileus, congenital megacolon, urinary retention Diagnosis and Treatment of Myasthenia Gravis Surmounting effects of competitive neuromuscular blocking agents Treatment of Alzheimer’s disease (increasing adverse cardiovascular events!!!) Treatment of Atropine poisoning (and al types of anticholinergic poisoning)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
25
Q

Diagnosis and Treatment of Myasthenia Gravis

A

Therapeutic Uses of Cholinesterase Inhibitors

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
26
Q

Postoperative ileus, congenital megacolon, urinary retention

A

Therapeutic Uses of Cholinesterase Inhibitors

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
27
Q

Glaucoma

A

Therapeutic Uses of Cholinesterase Inhibitors

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
28
Q

Surmounting effects of competitive neuromuscular blocking agents

A

Therapeutic Uses of Cholinesterase Inhibitors

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
29
Q

Treatment of Alzheimer’s disease (increasing adverse cardiovascular events!!!)

A

Therapeutic Uses of Cholinesterase Inhibitors

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
30
Q

Treatment of Atropine poisoning (and al types of anticholinergic poisoning)

A

Therapeutic Uses of Cholinesterase Inhibitors

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
31
Q

Treatment of Cholinesterase Inhibitor Poisoning

A

Contains: 1) Atropine to block M R effect 2) 2PAM becasue of the organophophate exposure, so 2PAM reactiviate the enzyme. Pralidoxime (2-PAM) for reactivation of enzyme (oxime group has high affinity for phosphorus) and is effective at the neuromuscular junction It does not take care for the N side so the paralysis of diaphragm and the CNS effects are problematic and need supportive therapy

32
Q

Methacholine

A

Therapeutic use if Direct-Acting cholinergic receptor agonist Bronchial Reactivity

33
Q

Hexamethonium

A

Nondepolarizing Ganglionic Blocking Agent Noncompetitive antagonist of the NN receptor (allosteric antagonism) Not used therapeutically but experimentally. Blocks the open state of the ion channel

34
Q

Trimethaphan

A

Nondepolarizing Ganglionic Blocking Agent Competitive Antagonist of the Nn receptor Used therapeutically

35
Q

Mecamylamine

A

Nondepolarizing Ganglionic Blocking Agent Competitive Antagonist of the Nn receptor Used therapeutically

36
Q

Nicotine

A

Depolarizing Ganglionic Blocking Agents Agonist at NN receptors (low concentrations) Stimulates release of catecholamines from the adrenal medulla Stimulates baroreceptors leading to vasoconstriction and tachycardia Higher concentrations lead to ganglionic blockade that proceeds through two distinct phases

37
Q

Characteristics of Neuromuscular Blocking Drugs

A

Agents do not produce analgesia or anesthesia Most are poorly absorbed (quaternary ammonium compounds) and do not cross BBB Usually administered intravenously

38
Q

d-Tubocurare; pancuronium, vecuronium, rapacuronium, rocuronium; and cisatracurium, atracurium, and mivacurium

A

Non-depolarizing Neuromuscular Blocking Drugs Competitive inhibition of ACh binding at the nAChR (NM) receptor (Stabilizing blockade) Rapidly developing muscle weakness followed by flaccid paralysis Curare is least selective among the agents as it also produces some ganglionic blockade and induces histamine release but no longer available in US (historical significance See notes

39
Q

Succinylcholine

Nicotine?

A

Depolarizing Neuromuscular Blocking Drugs

Inhibition of activation of the NM receptor similar to the blockade of NN receptor (Desensitization)

Muscle fasciculations (initial depolarization followed by increasing weakness leading to flaccid paralysis)

Desensitization occurs when end-plate is repolarized but not able to be activated by agonists

Blockade of initial part of phase II desensitization will not be reversed by cholinesterase inhibitors

40
Q

Therapeutic Uses of Neuromuscular Blocking Agents

A

Relax skeletal muscle during surgery Permit reduction in

anesthetic dose Assist with orthopedic procedures

Facilitate procedures involving skeletal muscle (e.g. intubation, laryngoscopy, endoscopy, ECT)

41
Q

Comparison of Characteristics of Long Acting Isoquinolines with other NM Blocking Agents

A
42
Q
A
43
Q

**Drug cuases Prolonged apnea **

A

•Adverse Effects Associated with Neuromuscular Blocking Agents

Succinylcholine

44
Q

Adverse Effects Associated with Neuromuscular Blocking Agents

A
  • Prolonged apnea (Succinylcholine)
  • Increased intraocular pressure, increased intragastric pressure, hyperkalemia (can produce cardiac arrest)
  • Muscle pain
  • Malignant Hyperthermia (combination of inhalational anesthetic/depolarizing agent)
45
Q

Effects of Cholinergic Receptor Stimulation:
Muscarinic Receptors

Wet and Wild (Mostly GI)

A
  • Nausea, belching, vomiting, cramps and defecation
  • Urination
  • Salivation, increased sweating
  • Bronchoconstriction, increased mucociliary secretion
  • Increased lacrimation, rhinorrhea
46
Q

Effects of Cholinergic Receptor Stimulation:
Muscarinic Receptors

Cardiovascular System (M2, M3)

A

•Decreased heart rate and rate of conduction

47
Q

Effects of Cholinergic Receptor Stimulation:
Muscarinic Receptors

Eye (M3)

A
  • Contraction of iris sphincter (miosis)
  • Contraction of ciliary muscle (accommodation)
48
Q

Organ System Effects of Muscarinic Cholinergic Receptor Antagonism

Central Nervous System (mainly scopolamine)

A

•Low Dose
–Drowsiness
–Amnesia
•Dreamless sleep

•High Dose (Jimson weed, Devil’s breath, burundanga, Borrachero tree):
–Excitement
–Confusion/disorientation
–Hallucinations
–Coma
–Loss of intention

49
Q

Organ System Effects of Muscarinic Cholinergic Receptor Antagonism

Eye

A

–Pupillary dilation (mydriasis)
–Paralysis of accommodation (cycloplegia)
–Increased intraocular pressure

50
Q

Organ System Effects of Muscarinic Cholinergic Receptor Antagonism

•Cardiovascular System

A

–Tachycardia
–Antagonizes vasodilation and hypotension produced by choline esters

51
Q

Comparison of Muscarinic Receptor Blockade versus Occupancy

A

The effect with increase dose of Atropine. The effect does mimick the R occupancy except for early stages. The best guess is its interacting with presynaptic M2 R

52
Q

Organ System Effects of Muscarinic Cholinergic Receptor Antagonism

•Respiratory System

A

–Bronchodilation
–Inhibits secretion and reduces mucociliary clearance
–Complete blockade of salivary secretion

53
Q

•Organ System Effects of Muscarinic Cholinergic Receptor Antagonism

•GI and Urinary Tract

A

–Inhibition of GI tone and peristalsis
–Inhibition of gastric acid secretion
–Urinary retention

54
Q
  • Organ System Effects of Muscarinic Cholinergic Receptor Antagonism
  • Skin
A

–Inhibits sweating

55
Q

Relative Sensitivity to Muscarinic Cholinergic Receptor Blockade

A

Atropine, the protypuical antimuscranic agent.

Increase in Atropine’s dose measures 4 outcomes:

decrease in salivation

decrease in micturition

decrease in accomodation

increase in H.R

56
Q

To which activity does Atropine has the greater potency?

A

Dry mouth is the hallmark side effect for Atropine.

(decrease in salivation)

57
Q

Ipratropium (Atrovent®)

A

Synthetic Muscarinic Antagonists

Interesting drug. It is a solution that you inhaled

58
Q

Tiotropium (Spiriva®)

A

Synthetic Muscarinic Antagonists

4° amines

It is inhaled powder. Why? Because these agents are 4° amines that are not soluble in water. So they use a solvent contains soya lecithin.

contraindicated in patients hypersensitive to soya lecithin or other food products (soy bean or peanuts) and used with caution in patients with prostatic hypertrophy

59
Q

•Tolteridine
•Oxybutynin
•Trospium
Darifenacin

A

Prototypical Synthetic Muscarinic Antagonists

Caution for most of the agents when used concomitantly with CYP3A4 inhibitors

60
Q

Tolteridine (Detrol®) and Fesoterodine (Toviaz®), Oxybutynin (Ditropan®, Oxytrol®, Gelnique®), Trospium (Spasmex®), Flavoxate (Urispas®), Darifenacin (Enablex®) and Solifenacin (VESIcare®)

A

•Synthetic Muscarinic Antagonists
Used to treat overactive bladder

61
Q

Solifenacin

A

Synthetic Muscarinic Antagonists

Used to treat overactive bladder

being most selective for M3 R

Caution for most of the agents when used concomitantly with CYP3A4 inhibitors

62
Q

Solifenacin, Darifenacin and Oxybutynin are somewhat selective for M3 receptors with Darifenacin being most selective

A

Synthetic Muscarinic Antagonists

are somewhat selective for M3 receptors with Darifenacin being most selective (selective but not specific)

Caution for most of the agents when used concomitantly with CYP3A4 inhibitors

63
Q

Tolteridine

A

•Synthetic Muscarinic Antagonists

Used to treat overactive bladder

Appear lest selective for M3R

Caution for most of the agents when used concomitantly with CYP3A4 inhibitors

extended durations of action (daily dosing)

64
Q

•Fesoterodine

A

Synthetic Muscarinic Antagonists

Used to treat overactive bladder

appear less selective M3

extended durations of action (daily dosing)

Caution for most of the agents when used concomitantly with CYP3A4 inhibitors

65
Q

•Oxybutynin

A

•Synthetic Muscarinic Antagonists

•Used to treat overactive bladder
somewhat selective for M3 receptors

Caution for most of the agents when used concomitantly with CYP3A4 inhibitors

66
Q

•Trospium

A

•Synthetic Muscarinic Antagonists

Used to treat overactive bladder

Caution for most of the agents when used concomitantly with CYP3A4 inhibitors

67
Q

•Darifenacin

A

•Synthetic Muscarinic Antagonists

•Used to treat overactive bladder
•Darifenacin being most selective
for M3 receptors

Caution for most of the agents when used concomitantly with CYP3A4 inhibitors

68
Q

•Flavoxate

A

•Synthetic Muscarinic Antagonists

Used to treat overactive bladder

Caution for most of the agents when used concomitantly with CYP3A4 inhibitors

69
Q

Solifenacin

A
  • Synthetic Muscarinic Antagonists
  • somewhat selective for M3 receptors

Caution for most of the agents when used concomitantly with CYP3A4 inhibitors

70
Q

Homatropine

A

Synthetic Muscarinic Antagonists

–Short acting analogue of atropine
–Used to produce brief mydriasis and cycloplegia
–Combined with hydrocodone as Hycodan® for use as an antitussive

Duration 1-3 days

71
Q

•Cyclopentolate (Cyclogyl®)

A

•Synthetic Muscarinic Antagonists

–Ultra short acting agents for ophthalmological examination
–Short-lived mydriasis and cycloplegia

Duration 1 day

72
Q

Tropicamide (Mydriacyl Ophthalmic®)

A

•Synthetic Muscarinic Antagonists

–Ultra short acting agents for ophthalmological examination
–Short-lived mydriasis and cycloplegia

Duration 0.25 days

73
Q

•Therapeutic Uses of Muscarinic Cholinergic Receptor Antagonists

A

Prevent motion sickness (Scopolamine) – transdermal patches

Produce sedation, amnesia and tranquilization (hallucinogenic properties exploited as well)

Produce mydriasis and cycloplegia

Inhibit salivation and respiratory tract secretions (e.g. hyperhidrosis or prior to and during surgery)

Treatment of asthma and COPD

Treatment of cholinomimetic poisoning (especially bradycardia and hypotension)

74
Q

Why anitmascarnic agents are C/I with patients with narrow angle glaucoma?

A

Because these agents dilate the pupil, so they move the iris away from the angle of the eye. So in patient who has narrow angle glaucoma, that angle is already compressed. Now if dilate the iris with these agents, you will block the out flow facility of the eye preventing fluid from passing.

75
Q

How to overcome the anitmascarnic blocking effects?

A

With Anitacytlcholinesterase inhibitor to increase the level of Ach in the synaptic cleft